Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...

Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...

Omeros Co. (NASDAQ:OMER – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the stock, Ratings reports. Two investment ...

Researchers find that certain antioxidant enzymes, called selenoproteins, significantly contribute to fighting cell aging. The team used a gene knockout mouse model to help them study the effects of ...

SCF is essential for the maintenance and expansion of hematopoietic stem cells, which are critical in bone marrow transplants ...

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced it will present positive results from the pivotal ...

In the animal kingdom, the vertebrate intestine is renowned for its regenerative capacity, a vital process for maintaining ...

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells. This vital function is often disrupted in ...

Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic ...